Cancer Research Cancer Epigenetics EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 776-780, February 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y. M.
Right arrow Articles by Broome, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y. M.
Right arrow Articles by Broome, J. D.
[Cancer Research 59, 776-780, February 15, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

Arsenic Targets Tubulins to Induce Apoptosis in Myeloid Leukemia Cells

Yong Ming Li1 and John D. Broome

Department of Laboratories, North Shore University Hospital, Manhasset, New York 11030 and Department of Pathology, New York University School of Medicine, New York, New York 10016

Arsenic exhibits a differential toxicity to cancer cells. At a high concentration (>5 µM), As2O3 causes acute necrosis in various cell lines. At a lower concentration (0.5–5 µM), it induces myeloid cell maturation and an arrest in metaphase, leading to apoptosis. As2O3-treated cells have features found with both tubulin-assembling enhancers (Taxol) and inhibitors (colchicine). Prior treatment of monomeric tubulin with As2O3 markedly inhibits GTP-induced polymerization and microtubule formation in vitro but does not destabilize GTP-induced tubulin polymers. Cross-inhibition experiments indicate that As2O3 is a noncompetitive inhibitor of GTP binding to tubulin. These observations correlate with the three-dimensional structure of ß-tubulin and suggest that the cross-linking of two vicinal cysteine residues (Cys-12 and Cys-213) by trivalent arsenic inactivates the GTP binding site. Furthermore, exogenous GTP can prevent As2O3-induced mitotic arrest.




This article has been cited by other articles:


Home page
 Toxicol SciHome page
W. J. Jo, A. Loguinov, H. Wintz, M. Chang, A. H. Smith, D. Kalman, L. Zhang, M. T. Smith, and C. D. Vulpe
Comparative Functional Genomic Analysis Identifies Distinct and Overlapping Sets of Genes Required for Resistance to Monomethylarsonous Acid (MMAIII) and Arsenite (AsIII) in Yeast
Toxicol. Sci., October 1, 2009; 111(2): 424 - 436.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
R Colognato, F Coppede, J Ponti, E Sabbioni, and L Migliore
Genotoxicity induced by arsenic compounds in peripheral human lymphocytes analysed by cytokinesis-block micronucleus assay
Mutagenesis, July 1, 2007; 22(4): 255 - 261.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
R. D. Couch, N. J. Ganem, M. Zhou, V. M. Popov, T. Honda, T. D. Veenstra, M. B. Sporn, and A. C. Anderson
2-Cyano-3,12-dioxooleana-1,9(11)-diene-28-oic Acid Disrupts Microtubule Polymerization: A Possible Mechanism Contributing to Apoptosis
Mol. Pharmacol., April 1, 2006; 69(4): 1158 - 1165.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
G. McCollum, P. C. Keng, J. C. States, and M. J. McCabe Jr.
Arsenite Delays Progression through Each Cell Cycle Phase and Induces Apoptosis following G2/M Arrest in U937 Myeloid Leukemia Cells
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 877 - 887.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Z. Diaz, M. Colombo, K. K. Mann, H. Su, K. N. Smith, D. S. Bohle, H. M. Schipper, and W. H. Miller Jr
Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in APL and other malignant cell lines
Blood, February 1, 2005; 105(3): 1237 - 1245.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
L.-H. Yih, S.-W. Hsueh, W.-S. Luu, T. H. Chiu, and T.-C. Lee
Arsenite induces prominent mitotic arrest via inhibition of G2 checkpoint activation in CGL-2 cells
Carcinogenesis, January 1, 2005; 26(1): 53 - 63.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G. Sciandrello, F. Caradonna, M. Mauro, and G. Barbata
Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells
Carcinogenesis, March 1, 2004; 25(3): 413 - 417.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
J. McCafferty-Grad, N. J. Bahlis, N. Krett, T. M. Aguilar, I. Reis, K. P. Lee, and L. H. Boise
Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells
Mol. Cancer Ther., November 1, 2003; 2(11): 1155 - 1164.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L.-H. Yih and T.-C. Lee
Induction of C-Anaphase and Diplochromosome through Dysregulation of Spindle Assembly Checkpoint by Sodium Arsenite in Human Fibroblasts
Cancer Res., October 15, 2003; 63(20): 6680 - 6688.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
G. Mufti, A. F. List, S. D. Gore, and A. Y.L. Ho
Myelodysplastic Syndrome
Hematology, January 1, 2003; 2003(1): 176 - 199.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J.-D. Jiang, L. Denner, Y.-H. Ling, J.-N. Li, A. Davis, Y. Wang, Y. Li, J. Roboz, L.-G. Wang, R. Perez-Soler, et al.
Double Blockade of Cell Cycle at G1-S Transition and M Phase by 3-Iodoacetamido Benzoyl Ethyl Ester, a New Type of Tubulin Ligand
Cancer Res., November 1, 2002; 62(21): 6080 - 6088.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y.-H. Ling, J.-D. Jiang, J. F. Holland, and R. Perez-Soler
Arsenic Trioxide Produces Polymerization of Microtubules and Mitotic Arrest before Apoptosis in Human Tumor Cell Lines
Mol. Pharmacol., September 1, 2002; 62(3): 529 - 538.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. H. Miller Jr., H. M. Schipper, J. S. Lee, J. Singer, and S. Waxman
Mechanisms of Action of Arsenic Trioxide
Cancer Res., July 15, 2002; 62(14): 3893 - 3903.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
J. L. Slack, S. Waxman, G. Tricot, M. S. Tallman, and C. D. Bloomfield
Advances in the Management of Acute Promyelocytic Leukemia and Other Hematologic Malignancies with Arsenic Trioxide
Oncologist, April 1, 2002; 7(90001): 1 - 13.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
G. Sciandrello, R. Barbaro, F. Caradonna, and G. Barbata
Early induction of genetic instability and apoptosis by arsenic in cultured Chinese hamster cells
Mutagenesis, March 1, 2002; 17(2): 99 - 103.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Dvorakova, C. M. Payne, M. E. Tome, M. M. Briehl, M. A. Vasquez, C. N. Waltmire, A. Coon, and R. T. Dorr
Molecular and Cellular Characterization of Imexon-resistant RPMI8226/I Myeloma Cells
Mol. Cancer Ther., January 1, 2002; 1(3): 185 - 195.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
S. Waxman and K. C. Anderson
History of the Development of Arsenic Derivatives in Cancer Therapy
Oncologist, April 1, 2001; 6(90002): 3 - 10.
[Abstract] [Full Text]

Home page
 The OncologistHome page
A. J. Murgo
Clinical Trials of Arsenic Trioxide in Hematologic and Solid Tumors: Overview of the National Cancer Institute Cooperative Research and Development Studies
Oncologist, April 1, 2001; 6(90002): 22 - 28.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
R. Uslu, U. A. Sanli, C. Sezgin, B. Karabulut, E. Terzioglu, S. B. Omay, and E. Goker
Arsenic Trioxide-mediated Cytotoxicity and Apoptosis in Prostate and Ovarian Carcinoma Cell Lines
Clin. Cancer Res., December 1, 2000; 6(12): 4957 - 4964.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. J. McCabe Jr., K. P. Singh, S. A. Reddy, B. Chelladurai, J. G. Pounds, J. J. Reiners Jr., and J. C. States
Sensitivity of Myelomonocytic Leukemia Cells to Arsenite-Induced Cell Cycle Disruption, Apoptosis, and Enhanced Differentiation Is Dependent on the Inter-Relationship between Arsenic Concentration, Duration of Treatment, and Cell Cycle Phase
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 724 - 733.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
K. Hossain, A. A. Akhand, M. Kato, J. Du, K. Takeda, J. Wu, K. Takeuchi, W. Liu, H. Suzuki, and I. Nakashima
Arsenite Induces Apoptosis of Murine T Lymphocytes Through Membrane Raft-Linked Signaling for Activation of c-Jun Amino-Terminal Kinase
J. Immunol., October 15, 2000; 165(8): 4290 - 4297.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. André, D. Braguer, G. Brasseur, A. Gonçalves, D. Lemesle-Meunier, S. Guise, M. A. Jordan, and C. Briand
Paclitaxel Induces Release of Cytochrome c from Mitochondria Isolated from Human Neuroblastoma Cells
Cancer Res., October 1, 2000; 60(19): 5349 - 5353.
[Abstract] [Full Text]

Home page
 BloodHome page
G. Fang, C. N. Kim, C. L. Perkins, N. Ramadevi, E. Winton, S. Wittmann, and K. N. Bhalla
CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs
Blood, September 15, 2000; 96(6): 2246 - 2253.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. J. Roboz, S. Dias, G. Lam, W. J. Lane, S. L. Soignet, R. P. Warrell Jr, and S. Rafii
Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis
Blood, August 15, 2000; 96(4): 1525 - 1530.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Puccetti, S. Güller, A. Orleth, N. Brüggenolte, D. Hoelzer, O. G. Ottmann, and M. Ruthardt
BCR-ABL Mediates Arsenic Trioxide-induced Apoptosis Independently of Its Aberrant Kinase Activity
Cancer Res., July 1, 2000; 60(13): 3409 - 3413.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
W. H. Park, J. G. Seol, E. S. Kim, J. M. Hyun, C. W. Jung, C. C. Lee, B. K. Kim, and Y. Y. Lee
Arsenic Trioxide-mediated Growth Inhibition in MC/CAR Myeloma Cells via Cell Cycle Arrest in Association with Induction of Cyclin-dependent Kinase Inhibitor, p21, and Apoptosis
Cancer Res., June 1, 2000; 60(11): 3065 - 3071.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Perkins, C. N. Kim, G. Fang, and K. N. Bhalla
Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-xL
Blood, February 1, 2000; 95(3): 1014 - 1022.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
N.-O. Ku, X. Zhou, D. M. Toivola, and M. B. Omary
The cytoskeleton of digestive epithelia in health and disease
Am J Physiol Gastrointest Liver Physiol, December 1, 1999; 277(6): G1108 - G1137.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. S. Lew, S. L. Brown, R. J. Griffin, C. W. Song, and J. H. Kim
Arsenic Trioxide Causes Selective Necrosis in Solid Murine Tumors by Vascular Shutdown
Cancer Res., December 1, 1999; 59(24): 6033 - 6037.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.